Trial Profile
Assessing the immunogenicity of pneumococcal vaccination given as soon as possible after diagnosis to children and adolescents with leukaemia
Status:
Active, no longer recruiting
Phase of Trial:
Phase III
Latest Information Update: 22 Jun 2016
Price :
$35
*
At a glance
- Drugs Pneumococcal 10-valent vaccine conjugate (Primary)
- Indications Pneumococcal infections
- Focus Pharmacodynamics
- Acronyms PreventIPD
- 26 Apr 2011 Status changed from recruiting to active, no longer recruiting as reported by Australian New Zealand Clinical Trials Registry.
- 10 Jul 2009 New trial record.